Preparation and Evaluation of Long-Acting Injectable Levocetirizine Prodrug Formulation
<b>Background/Objectives</b>: Levocetirizine (LCZ) is a second-generation antihistamine with minimal central nervous system effects. However, its short half-life necessitates daily dosing, potentially reducing adherence in pediatric populations. This study aimed to develop a long-acting...
Saved in:
Main Author: | |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-06-01
|
Series: | Pharmaceutics |
Subjects: | |
Online Access: | https://www.mdpi.com/1999-4923/17/7/806 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Be the first to leave a comment!